Bansal, Priya
Hare, Nathan
Bajowala, Sakina S.
Abramson, Stuart L.
Chervinskiy, Sheva
Corriel, Robert
Hauswirth, David W.
Kakumanu, Sujani
Mehta, Reena
Rashid, Quratulain
Rupp, Michael R.
Shih, Jennifer
Mosnaim, Giselle S.
Funding for this research was provided by:
Shire
Teva Pharmaceutical Industries
Takeda Pharmaceuticals U.S.A.
AstraZeneca
GlaxoSmithKline
CSL Behring
This article is maintained by: Elsevier
Article Title: Reply to “The forced renaissance of telemedicine during COVID-19: A fellow-in-training's perspective”
Journal Title: The Journal of Allergy and Clinical Immunology: In Practice
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jaip.2020.11.056
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.jaip.2020.11.057
Content Type: simple-article
Copyright: © 2020 American Academy of Allergy, Asthma & Immunology